Mood Disorders Information Center
The declining rates for lithium use are linked to the burden of side effects and toxicity associated with the drug.
Men with diabetes, but not women, had excess mortality risk associated with depression and anxiety.
Some aspects of depression literacy were lower among patients with depression.
Comorbid panic disorder was linked to increased likelihood of side effects during treatment for depression.
Two studies found that psilocybin (magic mushrooms) treatment was effective for anxiety and depression.
The position statement provides recommendations for psychosocial assessment and care of individuals with diabetes.
Electroconvulsive therapy is effective for depression in patients with suicidal ideation and resistance to other treatments.
About one-third of patients with MCI are also diagnosed with depression.
The Mood Zoom questionnaire rates anxiety, elation, sadness, anger, irritability, and energy on a 7-point scale.
The researchers found that the prevalence of anxiety was 21.3% and depression 27.2% in patients with HH.
Cognitive reserve in bipolar patients gives a possible explanation for the differences seen among patients in their ability to perform in neurocognitive tests.
The transition to standard time is likely to be associated with a negative psychological effect.
Patients taking memantine plus sertraline had significantly greater improvement and greater response rate.
Therapeutic drug monitoring and pharmacogenetic analyses may be useful in the optimization of clomipramine in nonresponders.
Depression can occur in approximately 1 in 5 patients who have chronic stable angina.